The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation

This article reviews the available data on the use of NOACs for primary and secondary stroke prevention in AF patients and describes specific patient populations to guide clinician in making the informed decision regarding appropriate use of those agents. It also addresses the use of NOACs early after acute stroke and use of thrombolysis while on NOAC.

http://link.springer.com/10.1007/s11910-016-0645-6

Source: Current Neurology and Neuroscience Reports - March 28, 2016 Category: Neuroscience Source Type: research